Related Experiment Video

Updated: Aug 23, 2026

Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue
10:28

Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue

Published on: July 17, 2018

Development of multiple lipomas during treatment with rosiglitazone in a patient with HIV-associated lipoatrophy

Derek D Mafong, Grace A Lee, Siegrid Yu

    AIDS (London, England)
    |July 29, 2004
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
    06:08

    Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

    Published on: May 19, 2023

    Related Experiment Videos

    Last Updated: Aug 23, 2026

    Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue
    10:28

    Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue

    Published on: July 17, 2018

    Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
    06:08

    Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

    Published on: May 19, 2023

    Related Concept Videos

    Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

    Oral Hypoglycemic Agents: Biguanides and Glitazones

    Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...

    Articles linked to this work by shared authors, journal, and citation graph.

    Demographic factors associated with skin barrier function in a large population-based study.

    JID innovations : skin science from molecules to population health·2026

    Implementation of State Prescription Drug Monitoring Program Mandatory Checking Requirements and Prescribed Opioid Analgesic Use Among Women With and Without HIV in The Women's Interagency HIV Study: A Longitudinal Observational Study Using Staggered Adoption Difference-in-differences Analyses.

    AIDS and behavior·2026

    Associations Between Cannabis Use and Inflammatory Biomarkers Among People with HIV.

    Cannabis and cannabinoid research·2026

    Pregnancies, live births, and heart structure and function in women with HIV.

    AIDS research and therapy·2026

    The Association Between Cannabis Use and Electrocardiographic Abnormalities in People Living With HIV.

    Journal of acquired immune deficiency syndromes (1999)·2025

    Menopause is associated with faster increases in insulin resistance in women with HIV.

    AIDS (London, England)·2025

    HIV-associated pulmonary arterial hypertension: improving survival despite persistent treatment gaps - a systematic review and meta-analysis.

    AIDS (London, England)·2026

    Real-life durability and virological outcomes of doravirine in people with multidrug-resistant HIV.

    AIDS (London, England)·2026

    Retention in care: is it still a clinically useful indicator for monitoring long-term engagement in HIV care in the treat-all era?

    AIDS (London, England)·2026

    Cancer incidence and risk factors among people with HIV in REPRIEVE.

    AIDS (London, England)·2026

    Effects of semaglutide on subclinical cardiovascular health in people with HIV.

    AIDS (London, England)·2026

    Antiretroviral therapy regimens initiated during pregnancy and risks of adverse perinatal outcomes.

    AIDS (London, England)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us